Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01781429 |
| Title | Phase I Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of BVD-523 in Patients With Advanced Malignancies |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | Yes |
| Sponsors | BioMed Valley Discoveries, Inc |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| UCLA Med-Hematology & Oncology | Los Angeles | California | 90095 | United States | Details | |
| Yale Cancer Center | New Haven | Connecticut | 06520 | United States | Details | |
| Florida Cancer Specialists and Research Group (Sarah Cannon Research Institute) | Sarasota | Florida | 34232 | United States | Details | |
| Massachusetts General Hospital (MGH) | Boston | Massachusetts | 02114 | United States | Details | |
| Washington University School of Medicine | Saint Louis | Missouri | 63110 | United States | Details | |
| Memorial Sloan-Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
| Sarah Cannon Research Institute Hospital at Vanderbilt | Nashville | Tennessee | 37203 | United States | Details | |
| Vanderbilt-Ingram Cancer Center | Nashville | Tennessee | 37212 | United States | Details | |
| UT M.D Anderson Cancer Center | Houston | Texas | 77030 | United States | Details |